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ABSTRACT
A Quality Improvement Initiative Regarding Ondansetron in the Prevention of Spinal
Anesthesia-Induced Hypotension
Kassidy Dell Nutter, BSN, SRNA
Spinal anesthesia is an excellent choice as the primary anesthetic for lower abdominal, perineal,
and lower extremity procedures. Spinal anesthesia boasts several distinct advantages over
general anesthesia. However, it is important to note that spinal anesthesia does not come without
risk. The most common adverse reaction of spinal anesthesia is hypotension. Anesthesia
providers use several methods to combat the hypotension that is so commonly associated with
spinal anesthesia. One emerging trend to prevent spinal anesthesia-induced hypotension (SAIH)
is the administration of ondansetron, a serotonin 5-hydroxytryptamine3 antagonist. Evidence has
shown that the administration of ondansetron just prior to spinal anesthesia administration may
decrease the prevalence of SAIH by blocking the serotonin receptors in the heart, thus preventing
the triggering of the Bezold-Jarisch Reflex, a triad of hypotension, bradycardia, and peripheral
vasodilation. Despite the mounting evidence supporting the use of ondansetron to prevent this
phenomenon, it has not been widely adopted as the standard of care. The purpose of this project
was to translate evidence-based anesthesia care of patients undergoing spinal anesthesia into
practice by increasing anesthesia provider knowledge regarding the efficacy of pre-spinal
anesthetic ondansetron in attenuating SAIH. An educational in-service was delivered to
anesthesia providers at a 292 private-bed community hospital in West Virginia regarding the
efficacy of ondansetron in the mitigation of SAIH in an attempt to increase provider knowledge
about the usefulness of this intervention. Nineteen anesthesia providers took part in the inservice. Pre- and post-intervention Likert surveys were delivered that assessed the providers’
knowledge regarding the intervention, current use of the intervention in his or her practice, and
willingness to adopt the intervention if sufficient evidence supports the change. It was concluded
that the in-service increased provider knowledge regarding the use of ondansetron in the
attenuation of SAIH and influenced an intended change in provider practice. Continuing
education should be utilized to inform the evolution of evidence-based practice in anesthesia.
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A Quality Improvement Initiative Regarding Ondansetron in the Prevention of Spinal
Anesthesia-Induced Hypotension
Over 40 million anesthetics are given each year in the United States, and spinal
anesthetics make up a large portion of this number (Kremers, et al., 2015). Spinal anesthesia is
indicated for lower abdominal, perineal, and lower extremity procedures. Evidence has shown
that spinal anesthesia in these cases has several advantages over general anesthesia including
decreased cost, complications, infections, and improved pain control (Matsken Ko & Chen,
2015). Matsken Ko & Chen (2015) also state a significant decrease in deep vein thrombosis,
pulmonary embolism, surgical time, and blood transfusion when spinal anesthesia is the primary
anesthetic. While there is plenty of evidence supporting the use of spinal anesthesia in these
procedures, it is also important to note that spinal anesthesia does not come without risk.
Mounting evidence claims that a commonly used intraoperative medication, ondansetron, has
been shown to mitigate one major risk associated with spinal anesthesia.
Problem Description
Hypotension is a common adverse reaction of spinal anesthesia. Hypotension is
commonly described as a systolic blood pressure <80-90 mmHg or a 20% decrease in the
patient’s baseline systolic blood pressure. The incidence of hypotension following spinal
anesthesia is estimated to occur in 15% to 33% of cases (Tubog et al., 2017). Spinal anesthesia
causes venous and arterial vasodilation. Hypotension from spinal anesthesia is thought to be
caused primarily by decreased systemic vascular resistance (SVR) and decreased central venous
pressure (CVP) that results from sympathetic blockade, as well as redistribution of the central
blood supply to the splanchnic circulation and lower extremities (Warltier et al., 2003).
Additionally, this redistribution of blood along with parasympathetic dominance, leads to a low-
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volume, hypercontractile ventricle. Cardiac hypercontractions can activate the serotonin
receptors in the left ventricle, leading to activation of the Bezold-Jarisch Reflex (BJR), a triad of
hypotension, bradycardia, and peripheral vasodilation (Nagelhout & Elisha, 2018). Hypotension
causes inadequate perfusion to the vital organs of the body, placing a patient at risk for
cerebrovascular accident, coronary hypoperfusion, and prerenal acute kidney injury.
Intraoperative mean arterial pressure less than 55 mmHg during non-cardiac surgery is
associated with increased risk for acute kidney injury and myocardial infarction (Brady &
Hogue, 2013).
Anesthesia providers utilize several different techniques to mitigate the unwanted effects
of spinal anesthesia on blood pressure. Some of the most commonly used techniques are fluid
pre-loading, which has been associated with cardiopulmonary complications and urine retention,
and prophylactic administration of vasopressors, as well as rescue administration of vasopressors
once hypotension has occurred, although no single technique has proven to be adequately
effective (Shin et al., 2018; Cyna et al., 2006). Vasopressor use is often effective, but it can cause
negative effects. Vasopressor use is associated with organ ischemia, hyperglycemia,
hyperlactatemia, increased myocardial oxygen demand, tachyarrhythmias, and fetal acidosis
(Russell, 2013). It is preferred to prevent hypotension rather than to treat it. An emerging trend in
the prevention of spinal anesthesia-induced hypotension (SAIH) is the use of ondansetron, a
serotonin 5-hydroxytryptamine3 (5-HT3) antagonist. Evidence has shown that the administration
of ondansetron just prior to spinal anesthesia administration may decrease the prevalence of
SAIH by blocking the serotonin receptors in the heart, thus preventing the triggering of the
Bezold-Jarisch Reflex (Nagelhout & Elisha, 2018).
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Problem Statement
The use of spinal anesthesia elicits physiological changes, and of these physiological
changes, hypotension is one of the most prevalent. It is well documented that acute hypotension
can lead to negative and life-threatening consequences. Ondansetron administration prior to
spinal anesthesia administration has not yet been widely adopted as a standard of care. This
project aimed to translate evidence-based anesthesia care of patients undergoing spinal
anesthesia by presenting this evidence to anesthesia providers, allowing them to make a more
informed decision regarding their delivery of care to this large patient population.
Available Knowledge
A literature search was performed using the population, intervention, comparison,
outcome (PICO) process (Larrabee, 2009) to develop the search question, “In anesthesia
providers caring for patients undergoing spinal anesthesia, does the delivery of an educational inservice regarding the usefulness of ondansetron to mitigate SAIH compared to no educational inservice increase provider knowledge as well as intent to incorporate the proposed change into
practice?” A critical appraisal of evidence was performed on all publications included in this
proposal and synthesized to contribute to the proposed design and evaluation of this project.
The project co-investigator searched the Academic Search Complete, CINAHL with Full
Text, Cochrane Library, Health Source: Nursing/Academic Edition, and MEDLINE electronic
databases. Full text, English language articles from 2014 to 2020 with links to full text that
evaluated the effectiveness of ondansetron administration prior to spinal anesthesia
administration in the attenuation of SAIH met the criteria for review and selection. Keyword
search combinations of spinal anesthesia, ondansetron or Zofran, hypotension, and SAIH were
used. The search yielded 80 relevant hits, in which inclusion criteria reduced the number of
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relevant articles to be included in this review of literature to eight: five randomized controlled
trials, two systematic reviews with meta-analysis, and one meta-analysis.
Literature Review Synthesis
Critical appraisals of the seven relevant articles were performed. A comprehensive
review of each publication will be presented in this section and include a summary of each
publication included in this review, the purpose of each study, sample size and characteristics,
outcome measures and findings, and recommendations from each publication. The measured
parameters were consistent across the studies, and no extreme biases were noted during this
review. An evaluation table of the evidence included in this literature review can be found in
Table 1.
A meta-analysis conducted by Gao et al. (2015) was conducted to assess prophylactic
effects of ondansetron on SAIH in obstetric and non-obstetric patients. Ten randomized clinical
trials with a total of 863 participants were included in this meta-analysis. Ondansetron was given
in doses of 8-12 milligrams (mg). Gao et al. found prophylactic ondansetron to reduce not only
hypotension in obstetric and non-obstetric patients (p = 0.002 and p = 0.0005) but also
bradycardia and vasopressor administration.
A prospective, randomized, controlled, double-blinded study conducted by Trabelsi et al.
(2015) investigated the use of intravenous ondansetron versus a placebo for prophylaxis of
hypotension after spinal anesthesia in parturients scheduled for elective cesarean section and its
consequences on newborns. This study included American Society of Anesthesiologists (ASA)
Physical Status classification I primipara patients. Eighty patients were included in the study
with 40 patients being randomly assigned to both the control group and the intervention group.
The intervention group received 4 mg of ondansetron five minutes prior to spinal anesthesia
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administration. An arterial line was utilized to monitor blood pressure every two minutes.
Hypotension was defined as a 20% or greater decrease from baseline or SAP less than 80 mmHg.
The authors found that only 15 (37.5%) of the 40 patients who received ondansetron developed
hypotension, while 31 (77.5%) participants in the placebo group developed hypotension (p <
0.001). The authors also discovered that the ondansetron group used an average of 5.10 mg of
ephedrine for blood pressure rescue, while the placebo group used 12.90 mg of ephedrine (p <
0.001).
Owczuk et al., (2015) conducted a prospective, randomized, controlled, double-blind
study in an attempt to verify the hypothesis that blocking type 3 serotonin receptors with
intravenous ondansetron reduces the hypotension induced by spinal anesthesia. Fifty-three
patients, aged 70 years and older, were included in the study. Twenty-six patients were randomly
assigned to the ondansetron group that received 8 mg of ondansetron diluted with normal saline,
and 27 patients were randomly assigned to the placebo group that received only normal saline.
Hypotension was defined as SBP less than 90 mmHg or a 20 percent decrease from baseline. The
authors found that SBP was significantly higher in the ondansetron group five minutes after the
block was established, and MAP and DBP were significantly higher at post-block intervals of
five, 10, and 15 minutes. The authors also found that ephedrine administration was significantly
lower (p = 0.049) in the ondansetron group.
Heesen et al. (2016) conduced a systematic review and meta-analysis with metaregression to determine whether 5-HT3 receptor antagonists, administered before the initiation of
spinal anesthesia, mitigate SAIH. Seventeen trials (eight obstetric and nine non-obstetric)
reporting on 1,604 patients were included in this review. The authors reported a 95% CI, 0.360.81, in the decreased risk for hypotension in obstetric and non-obstetric patients. The authors
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determined that 5-HT3 receptor antagonists are effective in reducing the incidence of
hypotension in patients undergoing spinal anesthesia.
A prospective, randomized, double-blinded, controlled study conducted by Karacaer et al.
(2017) assessed the effect of prophylactic ondansetron on the incidence of SAIH and
norepinephrine consumption. The study included 108 parturients with uncomplicated
pregnancies undergoing elective cesarean delivery under spinal anesthesia. The parturients were
randomly divided into two equal groups. The experimental group received 8 mg of ondansetron,
and the control group received the same volume in normal saline. The authors defined
hypotension as systolic blood pressure (SBP) less than 80% of baseline, and norepinephrine
consumption was measured in milligrams. This study found no statistically significant difference
in the incidence of patients with hypotension in the experimental group and the control group (p
= 0.767). However, cumulative episodes of hypotension and norepinephrine consumption were
significantly lower in the experimental group compared to the control group (p = 0.009). While
this study found no significant difference in the number of patients who experienced SAIH
among the two groups, it was discovered that patients who received 8 mg of prophylactic
ondansetron consumed significantly lower amounts of norepinephrine.
Another systematic review and meta-analysis of randomized controlled trials by Tubog et
al. (2017) was included in this literature review. The purpose of this study was to determine the
efficacy of intravenous ondansetron in reducing the incidence of SAIH and bradycardia. Thirteen
randomized controlled trials were included in the analysis. Nine of these studies included
patients undergoing elective cesarean section, and four trials reported on patients undergoing a
variety of surgical procedures in orthopedics, urology, and gynecology. Patients were divided
into two groups. The experimental group received ondansetron at varying doses (2-8 mg) prior to
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spinal anesthesia. The control group did not receive ondansetron prior to receiving spinal
anesthesia. Nine studies defined hypotension as a decrease in SBP by 75% from baseline, SBP
less than 80-90 mmHg, or both. One study defined hypotension as diastolic blood pressure
(DBP) less than 60 mmHg. Two studies used mean arterial pressure (MAP) to define
hypotension, but no values were given. The authors discovered that intravenous ondansetron
reduced the incidence of hypotension in both the cesarean and all-procedure groups with a risk
ratio (RR) of 0.64 and 95% CI of 0.45-0.90 and RR of 0.63 and 95% CI of 0.45-0.88,
respectively. Findings of this study suggest that ondansetron mitigates the risks of SAIH.
A randomized controlled trial performed by Mohamed et al. (2018) compared the
efficacy of the use of ondansetron alone compared to the combined use of fluid preload and
vasoconstrictors to decrease the incidence of spinal hypotension. Ninety patients of ASA grade I
between the ages of 18 and 45 years scheduled to undergo elective surgical procedures on the
lower extremity or lower abdomen under spinal anesthesia were included in this study. The
authors defined hypotension as a decrease of MAP more than 20% of the baseline or less than 70
mmHg. Patients in Group I received 4 mg of ondansetron 15 minutes before delivery of spinal
anesthesia. Patients in Group II received preloading with 7.5mL/kg/min of Ringer’s lactate over
a 10-minute period preceding the spinal block followed by a bolus of 2.5 mg of ephedrine in the
first and second minute and 2.5 mg of ephedrine every five minutes for the next 20 minutes after
the injection of spinal anesthesia. The study showed the incidence of hypotension following
spinal anesthesia in Group I was 17.6% versus 13.3% in Group II. The difference among the two
groups were statistically insignificant (p = 0.082). However, the study demonstrated that the
preemptive use of both combined fluid preload and vasoconstrictors and use of ondansetron
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alone significantly decreased the incidence of SAIH. Furthermore, the study goes on to conclude
that ondansetron can be used as a sole agent in decreasing the incidence of SAIH.
Wang et al. (2014) conducted a double-blind, randomized controlled trial to determine
the optimal dosage of ondansetron for preventing maternal hypotension during cesarean delivery.
They compared 2 mg, 4 mg, 6 mg, and 8 mg doses of ondansetron as well as a control group
with only normal saline. One hundred and fifty women undergoing elective cesarean section
were randomly divided into one of the five groups. Parturients were 18-35 years of age, were at
37-42 weeks of gestation, and classified as ASA grades I and II. In addition to hypotension, the
authors also analyzed serum parameters in umbilical cord blood after delivery. Maternal blood
pressure was measured by SBP, DBP, and MAP. Compared to the control group, the incidence
of maternal hypotension was obviously but not significantly reduced in experimental groups
receiving 2 mg and 8 mg of ondansetron (p > 0.05). However, the incidence of maternal
hypotension was significantly reduced in experimental groups receiving 4 mg and 6 mg of
ondansetron (p < 0.05). This study also discovered that consumption of phenylephrine in the
group receiving 4 mg of ondansetron was significantly less than that in the control group (p <
0.05). Furthermore, the pH of umbilical cord blood was significantly higher in the group
receiving 4 mg of ondansetron compared to the control group (p < 0.05), stating that the control
group exhibited cord blood of an acidotic state. The authors suggest that 4 mg is the optimal dose
due to the decrease in risk for maternal hypotension and the minimal effects on umbilical cord
blood.
The small sample sizes of the randomized controlled trials in this review contribute to
limitations of data interpretation. However, all three randomized controlled trials found
statistically significant evidence, as well as clinically relevant evidence, supporting the use of
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ondansetron administration prior to spinal anesthesia. The evidence suggests that ondansetron
does contribute to attenuating SAIH as evidenced by the decreased amount of vasopressor
consumption in each of the three randomized controlled trials reviewed. Additionally, the
systematic reviews provide overwhelming evidence that ondansetron is effective in mitigating
the effects of following spinal anesthesia in all-procedure patients and obstetric patients. This
literature review finds appropriate evidence to support incorporating prophylactic administration
of 4mg of ondansetron in all cases using spinal anesthesia to mitigate SAIH.
Rationale
The major theoretical framework that was utilized as a guide for this project was the
Plan-Do-Study-Act (PDSA) model. This four-step model is a straightforward, iterative approach
to quality improvement and can be easily adopted regardless of practice size or resources (“PlanDo-Study-Act,” n.d.). Furthermore, since the PDSA cycle is commonly used during the clinical
improvement process, it is often familiar to clinical staff even though the actual terminology of
the model may be unfamiliar. Therefore, the PDSA model proves itself to be useful in adapting
and implementing research-based interventions, especially where incorporation of the
intervention into day-to-day practice is a central question (Coury et al., 2017). Utilization of the
PDSA model involves following a prescribed four-stage cyclic learning approach to adapt
changes aimed at improvement (Taylor et al., 2014). During the “plan” stage of the model, a
changed aimed at improvement is identified. Next, the “do” stage sees this change tested. The
“study” stage evaluates the success of the change, and the “act” stage identifies adaptations and
next steps to inform a new cycle. The four steps of the model mirror the scientific experimental
method of forming a hypothesis, data collection to test the hypothesis, and interpreting the results
of the experiment. The PDSA model is a strong theoretical framework for this project due to its
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ability to incorporate rapid assessment and flexibility as feedback to ensure fit-for purpose
solutions are developed.
Another guiding theoretical framework was Duffy’s Model of Caring. Duffy (2018)
describes the importance of working with interprofessional teams to contribute to positive patient
outcomes. The model implies that developmental discussions, facilitation of learning
opportunities, and communication within the interprofessional team provides affirmative fuel for
creating success and positive change. In congruence with Duffy’s model, this project aimed to
translate evidence into familiar terms, demonstrate how the evidence contributes to patient
outcomes, describe the intervention, and provide examples that can contribute to team-based,
patient-centered care that optimizes value.
For the purposes of this project and to align with the PDSA and Duffy models, the
identified change aimed at improvement was to increase awareness and knowledge among
anesthesia providers regarding ondansetron as an effective agent in attenuating SAIH when
administered prior to spinal anesthesia. In the “do” stage, this project provided an educational inservice about the usefulness of ondansetron in mitigating SAIH. Evidence from the
aforementioned publications were presented to anesthesia staff, a question-and-answer session
was conducted, and comments and concerns were considered and addressed by the presenter.
The success of the change was evaluated through a pre- and post-survey that evaluated
anesthesia provider knowledge of the usefulness of ondansetron in mitigating SAIH prior to the
educational in-service and upon completion of the in-service. The post-survey also assessed the
anesthesia provider’s intent to incorporate the information into his or her practice when caring
for patients undergoing spinal anesthesia. Finally, the “act” stage involved refining the inservice, based on what was learned from the surveys as well as during the delivery of the in-
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service. New methods of information delivery, as well as anesthesia provider feedback and
perceptions, will be considered for future in-services.
Specific Aims
The specific aims of this project were: 1) to increase anesthesia provider awareness and
knowledge regarding the use of ondansetron to mitigate SAIH through an approximately 20minute-long educational in-service and 2) to present the evidence mentioned in this project’s
review of literature in a manner that may influence the participants to implement this proposed
change into practice
Methods
Context
The population focus of this project was anesthesia providers at a 292 private-bed
community hospital in West Virginia. The outcome evaluated was an increase in anesthesia
provider knowledge regarding the usefulness of ondansetron during spinal anesthesia,
ondansetron’s mechanism of action in preventing SAIH, the application of the intervention for
optimal results, and determining the participant’s intent to incorporate the proposed change into
practice.
Intervention
This quality improvement project strived to answer the question: Will an educational inservice regarding prophylactic ondansetron administration to attenuate SAIH increase anesthesia
provider knowledge and impact practice? Research suggests quality improvement training can
improve skills and knowledge among health professionals that may be associated with
improvements in care processes (Worsley, 2016). The project co-investigator collaborated with
the CRNA consultant for the project as well as the community hospital’s Chief CRNA to deliver
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an educational in-service regarding the use of ondansetron to mitigate hypotension in patients
undergoing spinal anesthesia. Success of the intervention was determined by pre- and postsurveys that assess an increase in anesthesia provider knowledge regarding the intervention as
well as intent to incorporate this intervention into practice.
The educational in-service was conducted during a monthly staff meeting to promote
anesthesia staff attendance. The in-service was held in a classroom that accommodates 40
occupants and was equipped with a large presentation monitor and necessary cable hook-ups for
a personal computer. Prior to the presentation, a five question Likert survey was conducted to
assess the provider’s knowledge regarding the application of ondansetron to mitigate SAIH,
ondansetron’s mechanism of action in mitigating SAIH, the optimal dosing of ondansetron for
SAIH, whether or not they currently applied this intervention in their individual practice, and
their willingness to change their practice if the in-service provided sufficient evidence to make a
change. Providers were instructed to omit any identifying information on the surveys. Evidence
regarding the intervention was then be delivered by the project co-investigator in a PowerPoint
presentation that lasted approximately 20 minutes. The PowerPoint presentation was developed,
stored, and accessed at the time of the in-service on the project co-investigator’s personal laptop
computer. Time was be allotted at the end of the presentation for questions and comments from
those in attendance. Upon completion of the question-and-answer session, a post-intervention
survey was distributed. The post-survey assessed the presentation’s success in enhancing
anesthesia provider knowledge along with intent to incorporate the intervention into the
providers’ practice.
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Gaps in Evidence
After discussions with several anesthesia providers, the need to increase provider
knowledge regarding this evidence-based intervention was identified so that providers may make
a more informed decision regarding their delivery of spinal anesthesia care to this patient
population. Upon further investigation, no evidence was identified that quantified the use of an
educational in-service to address a lack of knowledge and utilization of this evidence-based
practice among anesthesia providers. This quality improvement project may provide sufficient
evidence that an educational in-service regarding the use of ondansetron to attenuate SAIH
contributes to improved patient care achieved by anesthesia provider practice change for patients
undergoing spinal anesthesia.
Feasibility Analysis
Needs Assessment
After interviewing several Certified Registered Nurse Anesthetists (CRNAs), lack of
anesthesia provider knowledge regarding the usefulness of ondansetron in the attenuation of
SAIH was identified as a problem among anesthesia staff at a 292 private-bed community
hospital in West Virginia. Stakeholders for this project include the project investigator and coinvestigator, the community hospital’s Chief CRNA, and a CRNA employed by the community
hospital who acted as the consultant for this project.
Upon further assessment of implementation needs, no regulations were identified that
may conflict with the project. Furthermore, no extraordinary privacy, confidentiality, or security
issues were determined. After discussion with the established consultant for this quality
improvement project, implementation of the educational session component of this project would
not place any additional demands on staff or have any impact on workflow. The surgical
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department at the key site facility has regular meetings on the first Monday of every month
which provided an ideal opportunity for the implementation of this project. These meetings are
typically reserved for in-services and departmental issues such as quality improvement. Meetings
occur in classrooms that were equipped with all of the technological components needed for this
project. The educational in-service was delivered through a PowerPoint presentation that was
created, stored, and accessed from the project co-investigator’s personal computer.
Marketing and SWOT Analysis
The needs assessment of this project also included a SWOT analysis that identified
several strengths, weaknesses, opportunities, and threats. Some strengths of this project are that
workflow, staffing needs, and costs were not impacted. The cost of 4 mg/2 mL of ondansetron is
$0.28 - $1.35 per milliliter (Lexicomp Mobile Apps, n.d.). Furthermore, ondansetron is a
pregnancy Category B drug and is frequently prescribed to pregnant women to reduce
pregnancy-related nausea and vomiting (Parker et al., 2018). An additional strength of this
project includes the enhancement of CRNA knowledge regarding current evidence-based
practice. Weaknesses identified in this project include the presenter having no personal
experience with ondansetron administration in the attenuation of hypotension during spinal
anesthesia administration. Another weakness that was anticipated during the implementation of
this project was that department productivity may be impacted since all departmental business
must be completed during this monthly meeting. However, this was also deemed as an
opportunity. Knowing that the anesthesia department routinely meets every first Monday
morning of the month provided an ample opportunity to implement the intervention with
collaboration from the hospital’s Chief CRNA and project consultant. Another opportunity
considered during this SWOT analysis was the opportunity to provide this continuing education
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to the anesthesia department regarding the effectiveness of ondansetron in mitigating
hypotension under spinal anesthesia. This education can broaden the providers’ knowledge of the
care of this patient population. Threats identified during the SWOT analysis included pandemicrelated precautions which have restricted department meetings, lack of anesthesia provider trust
in the presenter due to the student presenter’s lack of experience, inattention of anesthesia staff
during the intervention, and reluctance of the anesthesia providers to translate this knowledge
into their practice.
Budget and Financial Plan
A budget plan was developed by the project co-investigator. Total anticipated costs
associated with this quality improvement project are minimal. Because the educational in-service
will take place during a regularly scheduled monthly meeting within the anesthesia department,
no administrative costs are anticipated. This project did hinder department or Operating Room
productivity, and it did not have any impact on anesthesia provider workflow. The cost for
educational materials and project supplies were minimal and at the project co-investigator’s
expense. A light breakfast was provided by the project co-investigator in the classroom before
the in-service to increase anesthesia provider attendance. No travel, marketing, or other expenses
related to this project were identified.
Personnel
Stakeholders for this project included anesthesia staff attending the educational inservice, the project’s consultant, and patients at the West Virginia community hospital
undergoing spinal anesthesia.
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Technology
Materials used for the delivery of the proposed educational in-service included the project
co-investigator’s personal computer and a large monitor with all essential cable hook-ups in the
classroom that the in-service was held. The project co-investigator created a PowerPoint
presentation on her personal computer. The PowerPoint presentation was stored and delivered
from the same computer. Surveys were hard-copy, paper surveys.
Sustainability of the Proposed Project
Sustainability will likely be satisfied by anesthesia providers transferring this knowledge
to new CRNA hires as well as future student registered nurse anesthetists. Another potential
source of sustainability would result from the inclusion of this in-service presentation with the
educational content required annually for anesthesia staff at this institution.
Congruence with the Organization’s Strategic Plan
This project aligned with the key site’s mission statement. The West Virginia community
hospital’s mission statement addresses the values and goals of the organization. The
organization’s mission statement states: “to enhance the healthy status of the citizens of North
Central West Virginia by pursuing spiritual, charitable, scientific and educational goals in
providing safe, quality care and treatment without discrimination as to gender, race, color,
religion, age, national origin, disabilities or financial status” (“The Future of Healthcare is Here,”
n.d.). This quality improvement educational session intended to broaden the knowledge of
anesthesia providers in the care of patients undergoing spinal anesthesia, and by doing so, will
contribute to the facility’s mission of providing quality care.
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Evidence of Key Site Support
Discussions were ongoing with the project’s key consultant and the hospital’s Chief
CRNA leading up to the time of intervention. The mission statement of the community hospital
clearly expresses support for this type of intervention. Written support was obtained from the
hospital’s Chief CRNA.
Project Timeline
West Virginia University Internal Review Board approval was granted in November
2020. Project implementation and data collection occurred in April 2021. Data analysis occurred
in September of 2021.
Ethical Considerations
Participation in the educational in-service delivered to anesthesia providers was
encouraged but in no way required. Participation was strictly voluntary. Identifying information
of anesthesia providers who chose to participate in the educational in-service was omitted from
surveys. No risks of this project’s intervention were identified. The proposal for this quality
improvement project was submitted for consideration to the IRB at WVU and was granted
approval of this research. There were no financial or other conflicts of interest concerning the
project and its implementation site or project researcher.
Measures
Measurable Project Objectives
The main objective of this project was to enhance anesthesia provider knowledge
regarding the use of ondansetron prior to spinal anesthesia to attenuate the hypotension prevalent
among this anesthetic technique. An additional objective to be evaluated was the anesthesia
provider’s intent to incorporate the proposed change into practice. Both objectives were
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measured with qualitative data gathered from the aforementioned post-survey. Increasing
anesthesia provider knowledge and awareness regarding this intervention should empower
providers to adapt their practice in order to deliver higher quality, evidence-based anesthesia care
to patients undergoing spinal anesthesia.
Evaluation Plan
An evaluation plan was created by the project co-investigator that included the project’s
specific aim, the population focus of the intervention, the outcome to be measured, and data
collection methods relevant to the outcome. Data for this project was collected with pre- and
post-surveys that assessed the success of the educational in-service delivered by the project coinvestigator. Results of the data collection may be applied to future offerings of this in-service.
No instruments of measurement were identified that complimented data collection
pertaining to this project, so instruments were constructed by the project co-investigator in
collaboration with the project investigator and CRNA consultant. The instruments developed for
data collection for this project were pre- and post- intervention Likert surveys consisting of five
questions on a 5-point scale for each instrument. These surveys can be found in Appendix C.
Because these surveys were constructed by the project’s team, their validity and reliability could
not be determined. These surveys were conducted prior to the in-service and immediately upon
the in-service’s completion. In order to enhance data collection, hard copies of both surveys were
distributed to and collected from the anesthesia providers.
Analysis
Data collected from the surveys was analyzed using International Business Machine’s
(IBM, 2020) Statistical Product and Service Solutions (SPSS) with the assistance and guidance
of a statistics expert. The pre- and post-intervention surveys contained ordinal variables, and a

19
Mann-Whitney U test was conducted to draw inferences between pre- and post-intervention
survey data. P values of <0.05 for statistical test analyses indicated a statistically significant
result. Surveys were assessed for participation and completeness.
Results
Nineteen CRNAs participated in this quality improvement initiative. Sample size for data
analysis was 19, a 100% response rate. A Mann-Whitney U test was conducted to evaluate the
statistical significance of the results. Results were considered significant if p-value was <0.05.
This intervention showed overwhelming effectiveness in increasing provider knowledge
regarding the use of ondansetron in the attenuation of SAIH. The results also showed
overwhelming effectiveness in influencing a practice change among the anesthesia providers
who participated. The educational in-service increased provider knowledge regarding
management of SAIH with a statistical significance of <0.001. The in-service also increased
knowledge about the use of ondansetron to attenuate SAIH with a statistical significance of
<0.001. The in-service increased provider knowledge regarding the optimum dosing of
ondansetron and intent to incorporate the intervention into future practice with statistical
significance of <0.001 for both assessments. 100% of participants reported they were willing to
make changes to their practice if evidence supported a change, and 100% of participants
indicated that the in-service provided sufficient evidence to influence a change in anesthesia
practice.
One barrier that was identified during the question and comment portion of the in-service
was regarding the anesthesia care delivery model at the community hospital. The CRNAs at the
community hospital practice under a team model in which they work under the medical direction
of an anesthesiologist. Several CRNAs voiced concerns about whether or not their attending
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anesthesiologists would be accepting of ondansetron given prior to a spinal anesthetic in
parturients undergoing cesarean section. It is recommended that anesthesiologists attend future
in-services, and more information is delivered regarding the safety of ondansetron administration
during pregnancy.
Unintended Consequences and Missing Data
The project’s intervention and data collection were conducted as designed; thus, no
unintended consequences were identified. Given the 100% response rate, no missing data was
identified. However, the sample size of this study was relatively small and only accounted for
roughly 70% of the CRNAs employed by the community hospital. In order to increase the
sample size and data collection, the in-service could have been delivered via a pre-recorded
presentation that was delivered to each provider’s e-mail address. In such case, surveys would
have been conducted through a digital platform. This method, however, may not deliver a high
participation rate due to the inconvenience of watching the presentation during the provider’s
free time and completing the surveys.
Discussion
Summary
Strengths of the project included the simplified intervention and data collection,
timeliness of data collection, and a foundation for sustainability by including the in-service in
annual or onboarding education. According to the data collected in this project, anesthesia
providers indicated an intent to incorporate the use of ondansetron to mitigate SAIH. This
change could provide an avenue for future investigators to conduct further studies regarding the
intervention’s effectiveness and contribute to future evidence-based practice. The minimal
disruption in workflow was also an identified strength. One last strength related to this quality
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improvement project was the positive feedback from participants regarding the quality and
delivery of the education.
Interpretation
The outcomes of this intervention satisfied the project’s aims and proved the intervention
to be successful. The observed outcomes were even better than anticipated outcomes, as provider
knowledge was statistically significantly increased in all categories and all participants reported
that they were willing to make changes to their practice based on the information that was
presented in the intervention. No additional costs were associated with the implantation of this
quality improvement initiative.
Limitations
As noted above, the CRNAs at the community hospital practice under the medical
direction of an anesthesiologist. This could potentially prove as a limiting factor in the CRNA
carrying out the intervention in their practice. Another limitation that was noted was the limited
reach of anesthesia providers at the community hospital. Not all CRNAs employed by the
hospital were given the opportunity to participate in the in-service. To address this, the in-service
could have been advertised prior to implementation, giving each CRNA an opportunity to attend.
Also, each CRNA could have been scheduled a time to attend the in-service, but this would have
dramatically affected workflow and increased costs for the organization.
Other limitations included the study’s generalizability. The study site was chosen due to
the lack of provider awareness regarding ondansetron’s usefulness in the mitigation of SAIH.
Outside of this particular community hospital, it is unclear whether this quality improvement
project would be useful elsewhere. However, it can be ascertained that in-services such as this
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one regarding evolving evidence-based practices are likely to enhance provider knowledge and
influence practice changes.
The internal validity of the study was identified as another possible limitation. Due to the
small sample size, statistical results were weakened. Furthermore, existing relationships between
the project’s co-investigator and study participants may have influenced the participants’ survey
responses. Conversely, the co-investigator’s lack of clinical experience with ondansetron’s use in
the attenuation of SAIH may have impacted the participants’ responses.
Conclusion
This quality improvement project was proven effective in addressing anesthesia provider
knowledge deficit regarding management of SAIH, the use on ondansetron to attenuate SAIH,
ondansetron’s mechanism of action to attenuate SAIH, as well as influencing a practice change
among providers who attended the in-service. It is recommended to include the in-service during
the onboarding process for new hires in order to address gaps in knowledge. The in-service may
be expanded to additional hospitals, pending an identified gap in knowledge. Follow-up
evaluation regarding the actual incorporation of the intervention in practice is also recommended
to contribute to further evidence-based practice.

.
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Appendix A
Table 1
Literature Review Synthesis Table
Year

Citation: Author,
Title, Country

Purpose of the
Study

Sample
Description

2014

Wang et al.,
Efficacy of
prophylactic
intravenous
ondansetron on the
prevention of
hypotension during
cesarean delivery: a
dose-dependent
study, China

to determine the
optimal dosage of
ondansetron for
preventing maternal
hypotension during
cesarean delivery

One hundred and
fifty parturient
women scheduled
for elective cesarean section were
randomly
assigned to five
groups (n=30).
Patients, aged 1835 years, were at
37-42 weeks of
gestation and
classified as
American Society
of Anesthesiologists (ASA)
grade I-II

Design /
Measures of
Major Variables
Double-blind
randomized
controlled trial

Major Variables
Being Measured

Findings

Independent:
IV1: Group S:
saline group

Maternal blood
pressure was
measured by
SBP, DBP, and
MAP

IV2: Group O2: 2
mg Ondansetron

Maternal heart
rate was
measured in bpm

IV4: Group O6: 6
mg ondansetron

Compared with
group S, the
incidence of
maternal
hypotension was
obviously but not
significantly
reduced in groups
O2 and O8 (P >
0.05), but
significantly
reduced in groups
O4 and O6 (P <
0.05)

Serum
parameters in
umbilical cord
blood were
analyzed after
delivery

IV3: Group O4: 4
mg Ondansetron

IV5: Group O8: 8
mg Ondansetron
Dependent:
DV1: maternal
BP
DV2: maternal
heart rate
DV3: serum
parameters in
cord blood

No bradycardia
or vomiting were
observed in
groups O4, O6,
and O8, but was
observed in
Group S
the consumption
of phenylephrine
in group O4 was
significantly less

28
Year

Citation: Author,
Title, Country

Purpose of the
Study

Sample
Description

Design /
Measures of
Major Variables

Major Variables
Being Measured

Findings

than that in group
S (P < 0.05)
The gas analysis
results from
umbilical arterial
blood showed
that there were no
significant
differences in pH,
Pco2, PO2,
Hco3-, or base
excess (P > 0.05
the pH of the
umbilical venous
blood was
significantly
higher in group
O4 compared
with group S (P <
0.05)

2015

Gao et al., Effects
of prophylactic
ondansetron on
spinal anesthesiainduced
hypotension:
a meta-analysis,
China

To assess
prophylactic
effects of
ondansetron on
spinal anesthesiainduced
hypotension in
obstetric and nonobstetric

10
randomized
clinical trials with
863 participants

Meta-analysis
Hypotension
defined as 20%
or greater
decrease from
baseline or SAP
in 9 studies, and

Independent:
IV1: patients
receiving
ondansetron prior
to spinal
IV2: patients who
did not receive

Ondansetron
reduced incidence
of hypotension in
the obstetric and
non-obstetric
groups, p = 0.002
and p = 0.0005,
respectively

29
Year

Citation: Author,
Title, Country

Purpose of the
Study
patients

Sample
Description

Design /
Measures of
Major Variables
<90 mmHg in 1
study.

Major Variables
Being Measured

Findings

ondansetron prior
to spinal

Bradycardia was
not defined

Dependent: DV1:
systolic blood
pressure

bradycardia after
prophylactic
ondansetron was
0.27 (95% CI
0.16 to 0.47,
P<0.0001) for
fixed effect
model
analysis and 0.34
(95% CI 0.19 to
0.61, P=0.0003)
for random
effects model
analysis,
indicating that
prophylactic
ondansetron
significantly
reduced the
incidence of
bradycardia
caused by spinal
anesthesia

Vasopressor use
was measured in
amounts given of
phenylephrine
and ephedrine

DV2: Heart rate
DV3: total use of
vasopressors

(95% CI -2.02 to
-0.40 mg),
suggesting
ephedrine used
was decreased in
patients using
ondansetron

30
Year

2015

Citation: Author,
Title, Country

Trabelsi et al.,
Effect of
Ondansetron on the
Occurrence of
Hypotension
and on Neonatal
Parameters during
Spinal Anesthesia
for
Elective Caesarean
Section: A
Prospective,
Randomized,
Controlled, DoubleBlind Study,
Tunisia

Purpose of the
Study

to investigate the
use of intravenous
ondansetron for
prophylaxis of
hypotension
after spinal
anesthesia in
parturients
scheduled for
elective caesarean
section and its
consequences on
newborns’
parameters

Sample
Description

ASA I primipara
patients
undergoing
elective CSection at term,
80 total patients,
exclusion criteria
were emesis
gravidarum,
contraindication
to spinal
anesthesia
(patient refusal,
unstable
hemodynamic,
and coagulation
abnormalities),
chronic
hypertension
or preeclampsia,
morbid obesity,
and/or any study
drugs
allergy

Design /
Measures of
Major Variables

Prospective,
randomized,
controlled,
double-blinded
study. Arterial
line was used to
monitor blood
pressure.
Systolic,
diastolic, and
mean arterial
pressures were
measured.
Hypotension was
defined as a 20%
or greater
decrease from
baseline or SAP
less than 80Heart
rate was also
measured.
Bradycardia was
defined as a 30%

Major Variables
Being Measured

Independent IV1:
Group O received
4 mg IV
ondansetron in 10
mL saline 5
minutes prior to
spinal.
IV2: Group S
received 10 mL
saline (placebo)
DV1: Systolic
Arterial Pressure
DV2: Diastolic
Arterial Pressure
DV3: Mean
Arterial Pressure
DV4: heartrate

Findings

(95% CI -57.46
to -4.87 μg,
P<0.05) suggests
that
phenylephrine
use was
decreased in
patients receiving
ondansetron.
SAP, DAP, MAP
higher in Group 0
4-10 minutes
after spinal.
Fewer patients in
the O group
experienced
hypotension
as compared to
those in the S
group: 15
(37.5%) and 31
(77.5%)
(𝑃 < 0.001). the
average
consumption of
ephedrine
intraoperatively
was 5.10 °æ 7.78
mg in group O
while it was
12.90 °æ 9.24 mg
in group S with a

31
Year

2015

Citation: Author,
Title, Country

Owczuk et al.,
Ondansetron
attenuates the
decrease in blood
pressure due to
spinal anesthesia in
the elderly: a double
blind, placebocontrolled study

Purpose of the
Study

To verify the
hypothesis that
blocking type 3
serotonin receptors
with intravenous
ondansetron
reduces the
hypotension

Sample
Description

ASA I-III patients
age 70 and older
without
contraindication
to subarachnoid
block or
ondansetron
administration.
Patients were

Design /
Major Variables
Measures of
Being Measured
Major Variables
drop in HR or HR
45 or less

Findings

Double-blind,
randomized
controlled trial.
NIBP
measurements
were used.
Hypotension was
defined as SBP
<90 mmHg or a

SBP was
significantly
higher 5 minutes
after the block
was established
in the
ondansetron
group. MAP and
DBP were

Independent IV1:
Ondansetron
group received 8
mg IV
ondansetron in
10mL saline 5
minutes prior to
spinal.

significant
difference (𝑃 <
0.001). HRs were
similar in both
groups and
bradycardia was
observed in 6
patients in group
O (15%), whereas
it was more
frequent in the S
group (15 cases,
37.5%) with a
significant
difference (𝑃 =
0.022). Atropine
consumption of
in group
S was 0.12 °æ
0.22 mg. No
atropine was
required in group
O.

32
Year

2016

Citation: Author,
Title, Country

Heesen et al.,
Prevention of Spinal
Anesthesia-Induced
Hypotension

Purpose of the
Study

Sample
Description

induced by spinal
anesthesia

randomized into
the ondansetron
group, which
received 8 mg of
IV ondansetron
diluted in 10mL
of normal saline 5
minutes prior to
the block and the
placebo group,
which received
only 10mL of
normal saline.
Fifty three total
patients were
included in the
study. here were
no significant
differences in the
patient age, body
weight, height,
sex, ASA
classification and
the frequency of
cardiovascular
disorders between
the groups.

to determine
whether 5hydroxytryptamine3
(5-HT3) receptor

Seventeen trials
(8 obstetric, 9
non-obstetric)
reporting on 1604
patients

Design /
Measures of
Major Variables
SBP decrease of
>20%.
Measurements
were recorded at
5, 10, and 15
minutes after
subarachnoid
block
administration.

Major Variables
Being Measured

Findings

IV2: Placebo
Group received
10mL NS 5
minutes prior to
spinal anesthesia.

significantly
higher at postblock intervals of
5, 10, and 15
minutes in the
ondansetron
group.

DV1: Systolic
Arterial Pressure
DV2: Mean
Arterial Pressure

Systematic
Review and
Meta-analysis
and Metaregression

Independent:
IV1: obstetric
patients receiving
prophylactic
ondansetron

Ephedrine was
administered to
12 (44.4%) of
individuals in the
placebo group
and to 5 (19.2%)
in the
ondansetron
group (p = 0.049)

Prophylactic use
of ondansetron in
the non-obstetric
and obstetric
groups showed

33
Year

Citation: Author,
Title, Country

Purpose of the
Study

During Cesarean
Delivery by 5Hydroxytryptamine3 Receptor
Antagonists: A
Systematic Review
and Meta-analysis
and Metaregression,
Switzerland

antagonists,
administered before
the initiation of
spinal anesthesia,
mitigate
hypotension

Sample
Description

Design /
Measures of
Major Variables

Major Variables
Being Measured

Hypotension as
defined by the
studies’ authors

IV2: nonobstetric patients
receiving
prophylactic
ondansetron

Findings

decreased risk for
hypotension, RR
0.54, 95% CI
0.36–0.81,
I2 = 79%.

IV3: obstetric
patients not
receiving
prophylactic
ondansetron
IV4: nonobstetric patients
not receiving
prophylactic
ondansetron

2017

Karacaer et al.,
Does prophylactic
ondansetron reduce
norepinephrine
consumption
in patients
undergoing
cesarean section

assess the effect of
prophylactic
ondansetron
on the incidence of
SAIH,
norepinephrine
consumption, and
adverse effects

108 parturients
with
uncomplicated
pregnancies
undergoing
elective cesarean
delivery under
spinal

Prospective,
randomized,
double-blinded,
controlled study

Hypotension
defined as SBP

DV1: incidence
of hypotension
among obstetric
and non-obstetric
patients
Independent:
IV1: Group O (n
= 54) received 8
mg ondansetron
Intravenously
IV2: Group S
received (n=54)
were

There was no
significant
difference in the
incidence of
patients with
hypotension in
the saline (n = 47,
87%) and
ondansetron

34
Year

Citation: Author,
Title, Country

Purpose of the
Study

with spinal
anesthesia?, Turkey

Sample
Description
anesthesia. The
parturients were
divided into two
groups randomly

Design /
Measures of
Major Variables
less than 80% of
baseline
Bradycardia
defined as HR <
60
Norepinephrine
consumption
measured in mg

Major Variables
Being Measured

Findings

given the same
volume (4 ml) of
saline (group S)
to establish
the double-blind
nature of the
study.

groups (n = 48,
88.9%) (p =
0.767).

Dependent: DV1:
SBP
DV2: HR
DV3:
Norepinephrine
consumption

2017

Tubog et al., Effects
of Ondansetron on
Attenuating Spinal
Anesthesia–Induced
Hypotension and
Bradycardia
in Obstetric and
Nonobstetric
Subjects:

to determine
the efficacy of
intravenous (IV)
ondansetron in
reducing
the incidence of
SIH and
bradycardia

Thirteen
RCTs were
included in this
analysis, totaling
1,225 subjects

Systematic
review and metaanalysis of
randomized
controlled trials
(RCTs)

Independent:
IV1: Group O
received
ondansetron at
varying doses
prior to spinal

hypotension as a
decrease in

IV2: Group S did
not receive

However,
cumulative
episodes of
hypotension and
norepinephrine
consumption
were significantly
greater in group S
than in group O
(p = 0.009 and p
= 0.009,
respectively)
Bradycardia was
observed in 11
(20.4%) patients
in
group O and 6
(11.1%) in group
S (p = 0.186).
Intravenous
ondansetron
reduced the
incidence of
hypotension in
both the allprocedure
analysis group

35
Year

Citation: Author,
Title, Country
A Systematic
Review and MetaAnalysis, United
States

Purpose of the
Study

Sample
Description

Design /
Measures of
Major Variables
systolic blood
pressure (SBP)
by 75% to 80%
of baseline, SBP
less than 80 to 90
mm Hg, or both.
One study
defined
hypotension as
diastolic blood
pressure less than
60 mm
Hg. Two studies
used mean
arterial pressure
to define
Hypotension
Bradycardia was
defined in beats
per minute. In 3
studies,
bradycardia was
defined as less
than 40 to 45/
min, in 5 studies
as less than
50/min,
and in 2 studies
as less than
60/min. One
study used

Major Variables
Being Measured

Findings

ondansetron prior
to spinal

(RR, 0.64; CI,
0.45-0.90) and
cesarean delivery
group
(RR, 0.63; CI,
0.45-0.88).
For bradycardia,
IV ondansetron
resulted in
reduced risk (RR,
0.31; CI, 0.190.50).
Findings suggest
that IV
ondansetron
may mitigate the
risks of SIH and
bradycardia
following
spinal anesthesia

36
Year

Citation: Author,
Title, Country

Purpose of the
Study

Sample
Description

Design /
Measures of
Major Variables
2 criteria to
define
bradycardia:
either a 30% drop
from
baseline or a
severe decline
below 45/min.
Two studies
did not
specifically
define
bradycardia

Major Variables
Being Measured

Findings

2018

Mohamed et al.,
Ondansetron Is an
Effective
Alternative to
Decrease the
Incidence of
Postspinal
Hypotension in
Healthy Subjects
Undergoing InfraUmbilical Surgeries
Compared To
Combined Volume
Loading and
Vasoconstrictors:
Randomized
Controlled Trial,
Egypt

To compare the
efficacy of the use
of ondansetron
alone compared to
the combined use of
fluid preload and
vasoconstrictors to
decrease the
incidence of spinal
hypotension

90 patients of
ASA grade I
between the age
of 18 and 45
years scheduled
to undergo
elective surgical
procedures on the
lower extremity
or lower abdomen
under spinal
anesthesia

Randomized
controlled trial

Independent:
IV1:
Group I patients
(ondansetron
group) received 4
mg ondansetron
in 5 ml normal
saline (IV) 15
minutes before
induction of
spinal anesthesia

The incidence of
hypotension
following the
subarachnoid
block in Group I
(ondansetron
group) was
17.6% versus
group II
(combination
group) was
13.3%, while
difference among
the groups is
statistically
insignificant (P =
0.082)

Hypotension was
defined as a
decrease of MAP
more than 20% of
the baseline or
less than 70
mmHg
Bradycardia was
defined as heart
rate < 60

IV2: Group II
patients
(combination
group) received
preloading with
7.5 ml/kg/min of
Ringer's lactate
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Year

Citation: Author,
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Purpose of the
Study

Sample
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Design /
Measures of
Major Variables

Major Variables
Being Measured

Findings

over 10-minute
period preceding
the spinal block
followed by
intravenous bolus
of 2.5 mg
ephedrine in the
first and second
minute and 2.5
mg ephedrine
every 5 minutes
for the next 20
minutes after the
injection of spinal
anesthetic drug

HR showed a
significant
increase in group
II and a
statistically
insignificant
change in group I
with a
statistically
significant
difference in the
heart rate (HR)
between both
groups (P < 0.05)

Dependent:
DV1: noninvasive
measurement of
MAP
DV2: heart rate
DV3: Reactive
hypertension

Ondansetron
alone did not
reduce
hypotension, but
it did decrease the
amount of
vasopressors
needed.
Ondansetron did
reduce the
incidence of
bradycardia
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Appendix B
Budget Plan Form and Justification
Budget Categories
ADMINISTRATIVE COSTS

Personal Funds
$0

Organizational
Contributions
$0

Administrative Justification: Because this in-service detailed in this project will be
conducted during a regularly scheduled monthly staff meeting within the anesthesia
department at United Hospital Center and will not impact workflow or Operating Room
productivity, there are no administrative costs associated with this project.
$0
$0
MARKETING
Marketing Justification: There is no marketing plan associated with this project.
EDUCATIONAL MATERIALS/
$5
$0
INCENTIVES
Educational Materials/Incentives Justification: This will cover the paper that the surveys will
be printed on, as well as printing costs at the project designer’s home.
HOSPITALITY (food, room rentals, $ 30
$0
etc.)
Hospitality Justification: Breakfast will be provided for staff at the beginning of the inservice to increase anesthesia provider attendance.
PROJECT SUPPLIES (office
$5
$0
supplies, postage, printing, etc.)
Project Supplies Justification: Pens will be provided by the project designer at the in-service.
$0
$0
TRAVEL EXPENSES
Travel Expenses Justification: There are no travel expenses related to this project.
OTHER
Other Justification:

$0

$0

TOTALS

$ 40

$0
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Appendix D
Pre-Intervention Survey
Strongly

Disagree

Neutral

Agree

Disagree

Strongly
Agree

I am aware that ondansetron is used to attenuate spinal
anesthesia-induced hypotension.

1

0

2

4

12

I have a good understanding of ondansetron’s mechanism of
action in attenuating spinal anesthesia-induced hypotension.

1

5

7

6

0

I know the recommended optimal doses of ondansetron for
obstetric and non-obstetric patients for the attenuation of
spinal anesthesia-induced hypotension.

1

4

8

4

2

I routinely give ondansetron to patients undergoing spinal
anesthesia prior to the establishment of the block, unless
contraindicated.

6

2

5

4

2

I’m willing to make changes to my practice if evidence
supports the change.

0

0

0

5

12
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Appendix E
Post-Intervention Survey
Strongly

Disagree

Neutral

Agree

Disagree

Strongly
Agree

This in-service increased my knowledge regarding the
management of spinal anesthesia-induced hypotension.

0

0

1

2

16

This in-service increased my knowledge about the use of
ondansetron in attenuating spinal anesthesia-induced
hypotension.

0

0

0

3

16

I’m confident that I know the optimal dosages of
ondansetron for obstetric and non-obstetric patients for the
attenuation of spinal anesthesia-induced hypotension.

0

0

0

3

16

Based on what was learned in this survey, I intend to
incorporate the proposed intervention into my future
practice.

0

0

0

4

15

I believe this in-service provided sufficient evidence to
influence a change in my anesthesia practice.

0

0

0

3

16
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Appendix F
Statistical Results
Question 1

Question 2
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Question 3

Question 4

